Drugs used to treat opioid use disorder may also be successful in improving the health outcomes of patients admitted to the hospital for injection drug use-associated endocarditis, according to research out of Boston.

Researchers at Imperial College London have developed a new type of sensor that can track vital signs in both humans and animals, suggesting the ever-growing wearables trend is expanding to include pets and livestock.

An analysis of the 2015 SPRINT trial has found that, if participants continued taking their antihypertensive medications for the remainder of their lives, intensive blood pressure control could add between six months and three years to their lifespan.

Pulsed field ablation technology has been used to treat atrial fibrillation for the first time in the U.S.

A wearable sensor developed by researchers at University of Utah Health and VA Salt Lake City Health Care System has the potential to predict heart failure complications more than a week before they occur.

Three-year data from the BIOFLOW-V trial, presented Feb. 23 at the 2020 CRT Congress in National Harbor, Md., reinforce the status of Biotronik’s Orsiro drug-eluting stent as superior to the popular Xience stent.

A study published Feb. 25 in Circulation suggests wearables are useful for detecting CV abnormalities like atrial fibrillation, but there’s still a long way to go before they can be trusted for clinical management.

Brain stents seem to be safe and effective in reducing the risk of recurrent stroke in patients who suffer from cholesterol-clogged brain arteries, according to research presented at the American Stroke Association’s International Stroke Conference.